August 17, 2026

Ongoing Trials: The EA8231 research study is testing a new treatment for advanced bladder cancer that continues to grow despite standard treatment

This trial aims to find out if the combination of targeted therapy and immunotherapy can provide greater benefit than standard chemotherapy